Active substance
Results for the substance conestat alfa
2 results
About this active substance
Conestat alfa is a recombinant C1 esterase inhibitor used for the treatment of hereditary angioedema. It works by inhibiting excessive activity of the complement system, thereby reducing symptoms such as swelling and pain.
The medication is administered via intravenous injection, usually during an acute episode of angioedema. The dose is determined by the physician based on the patient's weight and symptom severity. Common side effects include injection site reactions, headaches, and nausea.
Conestat alfa is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. Its use should also be carefully monitored to prevent severe allergic reactions.
This medication is an effective option for managing acute episodes of hereditary angioedema, providing rapid symptom relief and preventing complications.
The medication is administered via intravenous injection, usually during an acute episode of angioedema. The dose is determined by the physician based on the patient's weight and symptom severity. Common side effects include injection site reactions, headaches, and nausea.
Conestat alfa is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. Its use should also be carefully monitored to prevent severe allergic reactions.
This medication is an effective option for managing acute episodes of hereditary angioedema, providing rapid symptom relief and preventing complications.